Akums Drugs and Pharmaceuticals’ shares began trading at Rs 725, a 6.8% premium over the issue price of Rs 679, after an IPO that was subscribed 63.5 times. The company will use the IPO proceeds for debt repayment, working capital, and acquisitions. Revenue grew 14% in FY24, while profits saw a decline.
Sensex rises over 200 points, Nifty above 23,400 as investors eye RBI MPC meet outcome
Indian stock markets are trading higher today. Sensex and Nifty are extending their gains for a second day. Investors are keenly watching the Reserve Bank